The challenge of access to refined fungal diagnosis: An investment case for low- and middle-income countries

J Mycol Med. 2021 Jun;31(2):101140. doi: 10.1016/j.mycmed.2021.101140. Epub 2021 Apr 20.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antifungal Agents / therapeutic use
  • Clinical Laboratory Techniques / economics
  • Developing Countries / economics
  • Developing Countries / statistics & numerical data*
  • Disease Management
  • Fungi / pathogenicity
  • Global Health / statistics & numerical data
  • Humans
  • Income
  • Mycoses / diagnosis*
  • Mycoses / drug therapy
  • Mycoses / economics*
  • Mycoses / epidemiology
  • World Health Organization

Substances

  • Antifungal Agents